SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/761C2A0DEC9508F92F2C67FFB7C969A6D88C5601C85985C3C11084A9EF4C9FD4A6CA887A673C37FA1EEAC89033E447B3>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/761C2A0DEC9508F92F2C67FFB7C969A6D88C5601C85985C3C11084A9EF4C9FD4A6CA887A673C37FA1EEAC89033E447B3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/761C2A0DEC9508F92F2C67FFB7C969A6D88C5601C85985C3C11084A9EF4C9FD4A6CA887A673C37FA1EEAC89033E447B3
http://www.w3.org/2000/01/rdf-schema#comment
"Risk of early progression according to circulating ESR1 mutation CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_D48379FC20A879AD6052B53489DBEE0736EC1663BDE8C999B51E6706526F1FE3EEA34C216E93E3B971E3AB7FE7ABEDC3
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/761C2A0DEC9508F92F2C67FFB7C969A6D88C5601C85985C3C11084A9EF4C9FD4A6CA887A673C37FA1EEAC89033E447B3
http://purl.uniprot.org/uniprot/B6DU68
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/761C2A0DEC9508F92F2C67FFB7C969A6D88C5601C85985C3C11084A9EF4C9FD4A6CA887A673C37FA1EEAC89033E447B3
http://purl.uniprot.org/uniprot/#_B6DU68-mappedCitation-32466779
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/761C2A0DEC9508F92F2C67FFB7C969A6D88C5601C85985C3C11084A9EF4C9FD4A6CA887A673C37FA1EEAC89033E447B3